Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 312.50 | 180.13 | 238.00 | 243.75 | 0.9764 | 0.8935 |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 312.50 | 180.13 | 203.00 | 243.75 | 0.8328 | 0.3152 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 312.50 | 180.13 | 260.00 | 243.75 | 1.0667 | 1.3188 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 164.00 | 243.75 | 0.6728 | -0.1934 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 207.00 | 243.75 | 0.8492 | 0.3753 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 182.00 | 243.75 | 0.7467 | 0.0240 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 239.00 | 243.75 | 0.9805 | 0.9118 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 4 | 312.50 | 180.13 | 268.00 | 243.75 | 1.0995 | 1.4855 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 312.50 | 180.13 | 343.00 | 243.75 | 1.4072 | 3.3749 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 312.50 | 180.13 | 275.00 | 243.75 | 1.1282 | 1.6368 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 312.50 | 180.13 | 355.00 | 243.75 | 1.4564 | 3.7336 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 312.50 | 180.13 | 297.00 | 243.75 | 1.2185 | 2.1453 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 312.50 | 180.13 | 259.00 | 243.75 | 1.0626 | 1.2984 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 312.50 | 180.13 | 314.00 | 243.75 | 1.2882 | 2.5732 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 312.50 | 180.13 | 334.00 | 243.75 | 1.3703 | 3.1163 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 312.50 | 180.13 | 370.00 | 243.75 | 1.5179 | 4.2044 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 312.50 | 180.13 | 297.00 | 243.75 | 1.2185 | 2.1453 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 261.00 | 243.75 | 1.0708 | 1.3393 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 312.50 | 180.13 | 250.00 | 243.75 | 1.0256 | 1.1195 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 239.00 | 243.75 | 0.9805 | 0.9118 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 312.50 | 180.13 | 256.00 | 243.75 | 1.0503 | 1.2378 |
| SK-BR-3 | Etoposide | 0.01 | uM | 4 | 312.50 | 180.13 | 420.00 | 243.75 | 1.7231 | 5.9584 |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 312.50 | 180.13 | 199.00 | 243.75 | 0.8164 | 0.2565 |
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 312.50 | 180.13 | 272.00 | 243.75 | 1.1159 | 1.5713 |
| SK-BR-3 | Etoposide | 10 | uM | 4 | 312.50 | 180.13 | 153.00 | 243.75 | 0.6277 | -0.3120 |